- Bloomberg•1 hour ago
David Ricks, president and chief executive officer at Eli Lilly, and Indiana Governor Eric Holcomb discuss how changes to U.S. health coverage under the American Health Care Act may impact drug pricing ...
- Reuters•2 hours ago
Eli Lilly and Co said on Friday it would invest $850 million in its U.S. operations this year, and the drugmaker signaled it would be willing to spend more if the Trump administration were to overhaul tax laws. Lilly said investments would be made in research laboratories and manufacturing sites, mainly for its diabetes products. The move comes amid criticism from President Donald Trump about companies manufacturing abroad for U.S. consumers.
- PR Newswire•3 hours ago
INDIANAPOLIS, March 24, 2017 /PRNewswire/ -- Eli Lilly and Company (LLY) today announced plans to invest $850 million in its U.S. operations in 2017. David A. Ricks, Lilly's president and chief executive officer, said that Lilly's potential for growth and its long-standing commitment to the U.S. market led to its decision to invest in its U.S. operations and expand its manufacturing footprint in Indianapolis.
LLY : Summary for Eli Lilly and Company - Yahoo Finance
Eli Lilly and Company (LLY)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Bid||83.95 x 100|
|Ask||85.03 x 100|
|Day's Range||84.15 - 84.60|
|52 Week Range||64.18 - 86.14|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||32.69|
|Dividend & Yield||2.08 (2.47%)|
|1y Target Est||N/A|